The mechanisms of action for treatments of type 2 diabetes.
Leahy
John Jack
JJ
Division of Endocrinology, Diabetes and Metabolism,University of Vermont, Burlington, VT, USA.
D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology* / Q000628:therapy*; D052216:Glucagon-Like Peptide 1 / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use; D005947:Glucose / Q000378:metabolism; D006706:Homeostasis; D006801:Humans; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000502:physiology
D052216:Glucagon-Like Peptide 1; D005947:Glucose